Treatment agreements, informed consent, and the role of state medical boards in opioid prescribing

Pain Medicine (United States)

Volumn 16, Issue 1, 2015, Pages 25-29

  Mcgee, Summer ^a   Silverman, Ross D ^b  

^a UNIVERSITY OF NEW HAVEN   (United States)

^b INDIANA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OPIATE; NARCOTIC ANALGESIC AGENT;

ARTICLE; CONTRACT; DOCTOR PATIENT RELATION; DRUG ABUSE; HUMAN; INFORMED CONSENT; PRESCRIPTION; RESPONSIBILITY; TREATMENT RESPONSE; CLINICAL PRACTICE; OPIOID-RELATED DISORDERS;

ANALGESICS, OPIOID; HUMANS; INFORMED CONSENT; OPIOID-RELATED DISORDERS; PRACTICE PATTERNS, PHYSICIANS';

EID: 84921607972     PISSN: 15262375     EISSN: 15264637     Source Type: Journal    
DOI: 10.1111/pme.12580     Document Type: Article

References (24)

1. Centers for Disease Control and Prevention. Policy impact: prescription painkiller overdoses. 2013. Available at: http://www.cdc.gov/homeandrecreationalsafety/rxbrief/ (accessed September 10, 2013).
2. National Survey on Drug Use and Health. 2013. Available at: http://www.whitehouse.gov/ondcp/news-releases-remarks/national-survey-shows-friends-and-family-are-primary-sources-of-abused-painkillers (accessed March 18, 2014).
3. Jones CM, Paulozzi LJ, Mack KA. Sources of prescription opioid pain relievers by frequency of past-year nonmedical use, United States, 2008-2011. JAMA Intern Med 2014;174(5):802-803. doi: 10.1001/jamainternmed.2013.12809. Published online March 03, 2014.
4. United States Department of Justice, Office of Public Affairs, "Attorney General Holder, calling rise in heroin overdoses 'urgent public health crisis, ' vows mix of enforcement, treatment." 2014. Available at: http://www.justice.gov/opa/pr/2014/March/14-ag-246.html (accessed March 17, 2014).
5. Ramin CJ. Why Did the F.D.A. approve a new pain drug? New Yorker 2013. Available at: http://www.newyorker.com/online/blogs/currency/2013/12/zohydro-why-did-the-fda-approve-a-new-pain-drug.html (accessed March 17, 2014).
6. State Attorneys General. Letter from 28 state attorneys general to Margaret Hamburg, commissioner of food and drugs. 2013. Available at: http://www.oag.state.md.us/Press/Zohydro.pdf (accessed March 17, 2014).
7. Alliance of States with Prescription Monitoring Programs. "About the ASPMP." 2014. Available at: http://pmpalliance.org/about-the-aspmp/ (accessed March 10, 2014).
8. Fleming ML, Chandwani H, Barner JC, Weber SN, Okoro TT. Prescribers and pharmacists requests for prescription monitoring program (PMP) data: Does PMP structure matter? J Pain Palliat Care Pharmacother 2013;27(2):136-142. doi: 10.3109/15360288.2013.788598. [Epub 2013 May 20].
9. Indiana Register. 2013. Medical licensing board of Indiana. Emergency rule. LSA document # 13-495E.
10. Rudavsky S. "Measures would target abuse of painkillers in Indiana." 2013. Available at: http://www.indystar.com/article/20130821/LIFE02/308210082/Measures-would-target-abuse-painkillers-Indiana?nclick_check=1 (accessed September 8, 2013).
11. Indiana Prescription Drug Abuse Prevention Task Force, Education Committee, "First do no harm: the indiana healthcare providers guide to the safe, effective management of chronic non-terminal pain." Available at: http://www.in.gov/bitterpill/toolkit.html (accessed September 8, 2013).
12. Wieciak V Individual members of the medical licensing board of Indiana. United States district court, southern district of Indiana. 2014. Filed 01/08/14.
13. Heit HA, Gourlay DL. Tackling the difficult problem of prescription opioid misuse. Ann Intern Med 2010;152(11):747-748. doi: 10.7326/0003-4819-152-11-201006010-00013.
14. Starrels JL, Becker WC, Alford DP, etal. Systematic review: Treatment agreements and urine drug testing to reduce opioid misuse in patients with chronic pain. Ann Intern Med 2010;152(11):712-720. doi: 10.7326/0003-4819-152-11-201006010-00004.
15. Arnold RM, Han PK, Seltzer D. Opioid contracts in chronic nonmalignant pain management: Objectives and uncertainties. Am J Med 2006;119(4):292-296.
16. Penko J, Mattson J, Miaskowski C, Kushel M. Do patients know they are on pain medication agreements? Results from a sample of high-risk patients on chronic opioid therapy. Pain Med 2012;13(9):1174-1180. doi: 10.1111/j.1526-4637.2012.01430.x. [Epub 2012 Jul 3].
17. Hariharan J, Lamb GC, Neuner JM. Long-term opioid contract use for chronic pain management in primary care practice. A five year experience. J Gen Intern Med 2007;22(4):485-490.
18. Adams NJ, Plane MB, Fleming MF, etal. Opioids and the treatment of chronic pain in a primary care sample. J Pain Symptom Manage 2001;22(3):791-796.
19. Cheatle MD, Savage SR. Informed consent in opioid therapy: A potential obligation and opportunity. J Pain Symptom Manage 2012;44(1):105-116.
20. Goldberg DS. Job and the stigmatization of chronic pain. Perspect Biol Med 2010;53(3):425-438.
21. Bennett DS, Carr DB. Opiophobia as a barrier to the treatment of pain. J Pain Palliat Care Pharmacother 2002;16(1):105-109.
22. Federation of State Medical Boards of the United States. "Model policy on the use of opioid analgesics in the treatment of chronic pain." 2013. Available at: http://www.fsmb.org/pdf/pain_policy_july2013.pdf (accessed September 10, 2013).
23. Indiana Prescription Drug Abuse Prevention Task Force, Education Committee, "First do no harm: The Indiana healthcare providers guide to the safe, effective management of chronic non-terminal pain." 2013. Available at: http://www.in.gov/bitterpill/toolkit.html (accessed March 17, 2014).
24. Chou R, Fanciullo GJ, Fine PG, etal. Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J Pain 2009;10(2):113-130. doi: 10.1016/j.jpain.2008.10.008.